{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:10:21Z","timestamp":1790241021075,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2027,3]]},"DOI":"10.1016\/j.cca.2026.121351","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:04:17Z","timestamp":1789830257000},"page":"121351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical utility of the lipemic index for identifying severe triglyceride-rich lipoprotein disorders in adults undergoing routine blood testing"],"prefix":"10.1016","volume":"594","author":[{"given":"Pauline C.E.","family":"Schuitema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Kemperman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis A.","family":"Koekman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter W.","family":"van Solinge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond M.","family":"Schiffelers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. David","family":"Marais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank L.J.","family":"Visseren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Koopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cca.2026.121351_bb0005","first-page":"5","article-title":"Handling of lipemic samples in the clinical laboratory","volume":"4","author":"Fern\u00e1ndez Prendes","year":"2023","journal-title":"Adv. Lab. Med."},{"issue":"1","key":"10.1016\/j.cca.2026.121351_bb0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.11613\/BM.2014.008","article-title":"Lipemia: causes, interference mechanisms, detection and management","volume":"24","author":"Nikolac","year":"2014","journal-title":"Biochem. Med. (Zagreb)"},{"issue":"7","key":"10.1016\/j.cca.2026.121351_bb0015","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1515\/CCLM.2010.221","article-title":"The prevalence of preanalytical errors in a Croatian ISO 15189 accredited laboratory","volume":"48","author":"Simundic","year":"2010","journal-title":"Clin. Chem. Lab. Med."},{"issue":"1","key":"10.1016\/j.cca.2026.121351_bb0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1515\/CCLM.2010.006","article-title":"Evaluation of errors in a clinical laboratory: a one-year experience","volume":"48","author":"Goswami","year":"2010","journal-title":"Clin. Chem. Lab. Med."},{"issue":"1","key":"10.1016\/j.cca.2026.121351_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0262748","article-title":"The incidence rate and influence factors of hemolysis, lipemia, icterus in fasting serum biochemistry specimens","volume":"17","author":"Tian","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2026.121351_bb0030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cca.2019.10.024","article-title":"Lipemia index and screening for hyperlipidemia \u2013 a diagnostic opportunity?","volume":"501","author":"Gils","year":"2020","journal-title":"Clin. Chim. Acta"},{"issue":"8","key":"10.1016\/j.cca.2026.121351_bb0035","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1515\/cclm-2019-1270","article-title":"L-index, more than a screening tool for hypertriglyceridemia","volume":"58","author":"Delanghe","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"issue":"D6532","key":"10.1016\/j.cca.2026.121351_bb0040","article-title":"Een afwijkend lipidenprofiel [an abnormal lipid profile: when to perform additional research for a genetic cause?]","volume":"166","author":"Heidemann","year":"2022","journal-title":"Ned. Tijdschr. Geneeskd."},{"key":"10.1016\/j.cca.2026.121351_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2025.100978","article-title":"Recognition and management of persistent chylomicronemia: a joint expert clinical consensus by the National Lipid Association and the American Society for Preventive Cardiology","volume":"22","author":"Saadatagah","year":"2025","journal-title":"Am. J. Prev. Cardiol."},{"issue":"3","key":"10.1016\/j.cca.2026.121351_bb0050","doi-asserted-by":"crossref","first-page":"e703","DOI":"10.1210\/clinem\/dgae259","article-title":"Prevalence of Dysbetalipoproteinemia in the UK biobank according to different diagnostic criteria","volume":"110","author":"Paquette","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.cca.2026.121351_bb0055","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MED.0000000000000316","article-title":"Familial dysbetalipoproteinemia: an underdiagnosed lipid disorder","volume":"24","author":"Koopal","year":"2017","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"6","key":"10.1016\/j.cca.2026.121351_bb0060","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1373\/jalm.2018.028456","article-title":"The lipemia index: an underutilized tool to detect monoclonal proteins","volume":"3","author":"Agrawal","year":"2019","journal-title":"J. Appl. Lab. Med."},{"issue":"3","key":"10.1016\/j.cca.2026.121351_bb0065","doi-asserted-by":"crossref","first-page":"352","DOI":"10.11613\/BM.2012.037","article-title":"Investigation of unusual high serum indices for lipemia in clear serum samples on Siemens analysers Dimension","volume":"22","author":"Fliser","year":"2012","journal-title":"Biochem. Med. (Zagreb)"},{"key":"10.1016\/j.cca.2026.121351_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2025.120430","article-title":"The lipemia index: an efficient screening tool for identifying IgM paraprotein-mediated interference in the Beckman Coulter AU5800 uric acid assays","volume":"576","author":"Sun","year":"2025","journal-title":"Clin. Chim. Acta"},{"issue":"3","key":"10.1016\/j.cca.2026.121351_bb0075","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1515\/cclm-2023-0872","article-title":"Assessment of the lipemia index determined by the Atellica CH 930 analyzer for the detection of monoclonal immunoglobulins","volume":"62","author":"Thouault","year":"2023","journal-title":"Clin. Chem. Lab. Med."},{"issue":"2","key":"10.1016\/j.cca.2026.121351_bb0080","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1515\/CCLM.2006.040","article-title":"Comparison of triglyceride concentration with lipemic index in disorders of triglyceride and glycerol metabolism","volume":"44","author":"De Haene","year":"2006","journal-title":"Clin. Chem. Lab. Med."},{"issue":"1","key":"10.1016\/j.cca.2026.121351_bb0085","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1515\/cclm-2019-0609","article-title":"Are icteric and lipemic indices reliable to screen for hyperbilirubinemia and hypertriglyceridemia?","volume":"58","author":"Lippi","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2026.121351_bb0090","doi-asserted-by":"crossref","DOI":"10.1093\/jalm\/jfag066","article-title":"Unmasking hidden monoclonal proteins: leveraging the lipemia index","author":"Higgins","year":"2026","journal-title":"J. Appl. Lab. Med."},{"issue":"34","key":"10.1016\/j.cca.2026.121351_bb0095","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.cca.2026.121351_bb0100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/clinchem\/hvac161","article-title":"A translational tool to facilitate use of apolipoprotein B for clinical decision-making","volume":"69","author":"Cole","year":"2023","journal-title":"Clin. Chem."},{"issue":"3","key":"10.1016\/j.cca.2026.121351_bb0105","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jacc.2004.07.001","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","volume":"44","author":"Grundy","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.cca.2026.121351_bb0110","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.clinbiochem.2004.03.008","article-title":"Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with \u03b2-quantification in a large population","volume":"37","author":"Tremblay","year":"2004","journal-title":"Clin. Biochem."},{"issue":"6","key":"10.1016\/j.cca.2026.121351_bb0115","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"issue":"5","key":"10.1016\/j.cca.2026.121351_bb0120","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1056\/NEJM196702022760507","article-title":"Fat transport in lipoproteins \u2014 an integrated approach to mechanisms and disorders","volume":"276","author":"Fredrickson","year":"1967","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.cca.2026.121351_bb0125","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/ncpendmet0982","article-title":"A diagnostic algorithm for the atherogenic apolipoprotein B dyslipoproteinemias","volume":"4","author":"De Graaf","year":"2008","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.cca.2026.121351_bb0130","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2362.2010.02426.x","article-title":"Application and validation of a diagnostic algorithm for the atherogenic apoB dyslipoproteinemias: ApoB dyslipoproteinemias in a Dutch population-based study","volume":"41","author":"Holewijn","year":"2011","journal-title":"Eur. J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.cca.2026.121351_bb0135","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jacl.2007.07.006","article-title":"Diagnosis of type III hyperlipoproteinemia from plasma total cholesterol, triglyceride, and apolipoprotein B","volume":"1","author":"Sniderman","year":"2007","journal-title":"J. Clin. Lipidol."},{"issue":"3","key":"10.1016\/j.cca.2026.121351_bb0140","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2337\/diacare.25.3.579","article-title":"Hypertriglyceridemic HyperapoB in type 2 diabetes","volume":"25","author":"Sniderman","year":"2002","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.cca.2026.121351_bb0145","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)","volume":"41","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.cca.2026.121351_bb0150","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jacl.2020.06.004","article-title":"A simplified diagnosis algorithm for dysbetalipoproteinemia","volume":"14","author":"Paquette","year":"2020","journal-title":"J. Clin. Lipidol."},{"issue":"1","key":"10.1016\/j.cca.2026.121351_bb0155","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1194\/jlr.D200013-JLR200","article-title":"Non-denaturing polyacrylamide gradient gel electrophoresis for the diagnosis of dysbetalipoproteinemia","volume":"44","author":"Blom","year":"2003","journal-title":"J. Lipid Res."},{"issue":"25","key":"10.1016\/j.cca.2026.121351_bb0160","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the Management of Blood Cholesterol: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.cca.2026.121351_bb0165","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cca.2026.121351_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.hco.0000200416.65370.a0","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement","volume":"21","author":"Grundy","year":"2006","journal-title":"Curr. Opin. Cardiol."},{"issue":"9","key":"10.1016\/j.cca.2026.121351_bb0175","first-page":"1322","article-title":"Missing data in clinical research: a tutorial on multiple imputation","volume":"37","author":"Austin","year":"2021","journal-title":"Can. J. Cardiol."},{"issue":"5","key":"10.1016\/j.cca.2026.121351_bb0180","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/clinchem\/35.5.837","article-title":"Unreliable visual estimation of the incidence and amount of turbidity, hemolysis, and icterus in serum from hospitalized patients","volume":"35","author":"Glick","year":"1989","journal-title":"Clin. Chem."},{"issue":"6","key":"10.1016\/j.cca.2026.121351_bb0185","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.5114\/aoms.2019.86964","article-title":"Modern prevalence of the fredrickson-levy-lees dyslipidemias: findings from the very large database of lipids and national health and nutrition examination survey","volume":"16","author":"Sathiyakumar","year":"2020","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.cca.2026.121351_bb0190","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.metabol.2017.04.004","article-title":"High prevalence of apolipoprotein B dyslipoproteinemias in non-alcoholic fatty liver disease: the lifelines cohort study","volume":"72","author":"Nass","year":"2017","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.cca.2026.121351_bb0195","doi-asserted-by":"crossref","first-page":"993","DOI":"10.5114\/aoms.2019.86972","article-title":"Modern prevalence of dysbetalipoproteinemia (fredrickson-levy-lees type III hyperlipoproteinemia)","volume":"16","author":"Pallazola","year":"2019","journal-title":"Arch. Med. Sci."},{"issue":"11","key":"10.1016\/j.cca.2026.121351_bb0200","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1373\/clinchem.2004.038075","article-title":"Evaluating interference caused by lipemia","volume":"50","author":"Kroll","year":"2004","journal-title":"Clin. Chem."},{"issue":"6","key":"10.1016\/j.cca.2026.121351_bb0205","doi-asserted-by":"crossref","DOI":"10.1117\/1.JBO.28.6.065002","article-title":"Feasibility of postprandial optical scattering of lipoproteins in blood as an optical marker of cardiovascular disease risk: modeling and experimental validation","volume":"28","author":"Pilvar","year":"2023","journal-title":"J. Biomed. Opt."},{"issue":"5","key":"10.1016\/j.cca.2026.121351_bb0210","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1179\/acb.2004.039","article-title":"Protein precipitation as a possible important pitfall in the clinical chemistry analysis of blood samples containing monoclonal immunoglobulins: 2 case reports and a review of the literature","volume":"59","author":"Berth","year":"2004","journal-title":"Acta Clin. Belg."},{"issue":"3","key":"10.1016\/j.cca.2026.121351_bb0215","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1258\/acb.2008.008192","article-title":"A monoclonal protein identified by an anomalous lipaemia index","volume":"46","author":"Monk","year":"2009","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2026.121351_bb0220","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaf190","article-title":"Focused update of the 2019 ESC\/EAS guidelines for the management of dyslipidaemias","author":"Mach","year":"2025","journal-title":"Eur. Heart J."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126005334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126005334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:47:02Z","timestamp":1790239622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126005334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,3]]},"references-count":44,"alternative-id":["S0009898126005334"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.121351","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2027,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical utility of the lipemic index for identifying severe triglyceride-rich lipoprotein disorders in adults undergoing routine blood testing","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.121351","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"121351"}}